Original BioMedicals Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	909	919	756	1,186	852	852
Market Cap Growth	5.38%	21.62%	-36.31%	39.32%	0%	63.94%
Enterprise Value	847	731	488	1,177	805	774
Last Close Price	13.65	13.85	11.45	9.86	9.86	9.86
PS Ratio	-	2411.97	-	27591.98	7958.93	-
PB Ratio	8.19	5.82	2.96	3.63	12.31	7.81
P/TBV Ratio	8.23	5.82	2.96	3.63	12.31	7.81
EV/Sales Ratio	-	1918.61	-	27361.49	7521.31	-
Debt / Equity Ratio	0.08	0.07	0.05	0.05	0.29	0.19
Net Debt / Equity Ratio	-0.56	-0.84	-0.90	-0.96	-0.42	-0.57
Net Debt / EBITDA Ratio	0.62	1.33	3.10	5.72	0.81	2.28
Net Debt / FCF Ratio	0.50	1.37	2.67	11.23	0.94	2.33
Asset Turnover	-	0.00	-	0	0.00	-
Quick Ratio	4.30	9.37	17.66	11.39	5.68	10.91
Current Ratio	7.02	9.74	17.77	11.43	5.77	11.09
Return on Equity (ROE)	-63.64%	-49.15%	-25.78%	-30.15%	-45.18%	-46.07%
Return on Assets (ROA)	-35.35%	-28.22%	-15.06%	-15.81%	-21.33%	-19.94%
Return on Capital Employed (ROCE)	-88.40%	-62.60%	-29.60%	-17.40%	-45.80%	-25.40%
Earnings Yield	-11.25%	-11.05%	-9.93%	-5.03%	-4.73%	-3.98%
FCF Yield	-13.58%	-10.55%	-11.38%	-2.34%	-3.63%	-3.15%
Buyback Yield / Dilution	-1.08%	-0.72%	-33.68%	-4.87%	-13.05%	-50.66%